Topical moxifloxacin Shows Promise in Enhancing Post-Laparoscopy Wound Healing: Study Dr. Shravani Dali6 Jun 2025 10:00 PM ISTResearchers have found in a new Clinical trial that topical moxifloxacin may accelerate healing of therapeutic laparoscopy-induced wounds by reducing...
Omadacycline found promising for treatment of moderate to severe community-acquired bacterial pneumonia in phase 3 trial Dr. Kamal Kant Kohli21 July 2024 8:45 PM ISTIn a phase 3 clinical trial Omadacycline was found promising for treatment of moderate to severe community-acquired bacterial pneumonia compared to...
No shortage of TB drugs in India: Govt Ruchika Sharma14 Dec 2023 11:30 AM ISTNew Delhi: The Ministry of Health & Family Welfare has informed that there is no shortage of anti-tuberculosis drugs in the country....
Akums gets CDSCO Panel nod for Phase III CT of FDC Moxifloxacin, Nepafenac ophthalmic solution Dr. Divya Colin19 April 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin bests standard-care treatment for rifampin-resistant tuberculosis Medha Baranwal22 Dec 2022 8:00 AM ISTStandard-care treatment was similarly efficacious when patients could receive it without adverse effects, according to findings from a two-stage,...
Prescribe Moxifloxacin cautiously among diabetics as it has QTc prolonging effect Medha Baranwal1 Jun 2022 9:45 AM ISTUK: Hyperglycaemia is a significant cause of QTc prolongation in type 1 diabetes (T1D) patients and the additional effect of a a QTc-prolonging drug...
New tuberculosis regimen shortens treatment to four months: Study Hina Zahid16 Jun 2021 9:00 AM ISTShortening the treatment time improves adherence, decreases costs to programs and decreases the burdens on patients themselves.USA: A 4-month...
Four-month rifapentine regimen for TB equally effective as 6-month standard regimen: NEJM Medha Baranwal6 May 2021 6:45 AM ISTUSA: The effectiveness of a 4-month rifapentine-based regimen containing moxifloxacin is noninferior to the standard 6-month regimen for the treatment...
Oral antibiotics alone noninferior to IV followed by oral antibiotics in appendicitis patients: JAMA Medha Baranwal13 Jan 2021 11:02 AM ISTFinland: Adults with uncomplicated acute appendicitis treated with oral antibiotics versus IV followed by oral antibiotics had almost equal treatment...
Shorter TB treatment regimen as effective as longer course: CDC Study Medha Baranwal23 Oct 2020 7:13 PM ISTUSA: A four-month daily treatment containing high-dose rifapentine with moxifloxacin is as effective as the currently recommended six-month daily...
